German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening ... treat other skin diseases, such as palmoplantar ...
Timber's lead candidate TMB-001 for rare skin disease congenital ichthyosis failed to meet its efficacy objectives across the board in the ASCEND trial and will not support a planned regulatory ...
Those conditions, I reasoned, were rare. How people think about rare events ... I complained to my midwife of some itchy skin rashes that had popped up recently. She assured me that it was ...